Cian Healthcare Limited (BOM:542678)
100.18
+1.80 (1.83%)
At close: Jan 20, 2026
Cian Healthcare Revenue
Cian Healthcare had revenue of 113.22M INR in the half year ending September 30, 2025, a decrease of -65.28%. This brings the company's revenue in the last twelve months to 232.80M, down -51.68% year-over-year. In the fiscal year ending March 31, 2025, Cian Healthcare had annual revenue of 308.54M, down -50.15%.
Revenue (ttm)
232.80M
Revenue Growth
-51.68%
P/S Ratio
0.54
Revenue / Employee
1.26M
Employees
185
Market Cap
125.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 308.54M | -310.38M | -50.15% |
| Mar 31, 2024 | 618.92M | -67.84M | -9.88% |
| Mar 31, 2023 | 686.76M | -93.90M | -12.03% |
| Mar 31, 2022 | 780.66M | 41.25M | 5.58% |
| Mar 31, 2021 | 739.41M | 166.11M | 28.98% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sunrest Lifescience | 520.34M |
| Beryl Drugs | 191.97M |
| Unjha Formulations | 141.50M |
| Zenith Healthcare | 112.08M |
| Norris Medicines | 72.84M |
| Hamps Bio | 71.20M |
| Desh Rakshak Aushdhalaya | 62.53M |
| Colinz Laboratories | 58.72M |